Pemetrexed Combined With Synchronous Gefitinib as Adjuvent Therapy in Patient With EGFR Mutant Lung Adenocarcinoma
Clinical trial NCT02518802 · UNKNOWN
Trial details
- NCT number
- NCT02518802
- Sponsor
- Tang-Du Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2018-01-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.